Skip to content

Clinical trials

Phase 1/2 Uterine Cervical Dysplasia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Uterine Cervical Dysplasia Phase: Phase 1/2 Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20141
20171
20222

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Antiva Biosciences1
BioLeaders Corporation1
Erimos Pharmaceuticals1
GlaxoSmithKline1
National Cancer Institute (NCI)1
Photocure1
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Uterine Cervical Dysplasia7
Carcinoma in Situ1
Infections1
Papillomavirus Infections1
Precancerous Conditions1
Uterine Cervical Neoplasms1
Vulvar Diseases1
Vulvar Neoplasms1

Trials

Showing 76 to 7 of 7. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.